Introduction
T h e regulation of specific gene expression in response to changes in nutrition has become a major aspect of modern nutrition, due to the development of molecular biological techniques that have allowed the cloning of a number of genes involved in the regulation of carbohydrate and fat metabolism. It has been shown that major (glucose, fatty acids, amino acids) or minor (iron, vitamins) dietary constituents participate, in concert with many hormones, in the regulation of gene expression in response to nutritional changes (reviewed in [ 11) . This report is focused on the fetal-neonatal transition during which dramatic nutritional changes occur spontaneously and during which enzymes catalysing rate-limiting steps of fatty acid oxidation increase in the liver.
The perinatal period is attended by marked changes in the nutritional environment. In utero, the fetus is continuously supplied through the placenta with a diet rich in carbohydrates and amino acids and poor in fat (reviewed in [l]). Immediately after birth, the maternal supply of substrates ceases abruptly, and the newborn has to withstand a brief period of starvation before he is fed at intervals with milk which is a high fat (60% energy) and low carbohydrate (10% energy) diet. T o meet the energy needs of the newborn, the capacity for long-chain fatty acid (LCFA) oxidation increases rapidly in many tissues (liver, heart, skeletal muscles, lung, kidney cortex, small intestine, brown adipose tissue). In the liver, the increased oxidation of LCFA results in an enhanced rate of ketone body production.
In the mammalian liver, fatty acid oxidation can occur both in mitochondria and peroxisomes. During the last decade, the role and importance Abbreviations used: LCFA, long-chain fatty acids; CPT, carnitine palmitoyltransferase; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA; FFA, free fatty acids; ACS, acetyl-CoA synthetase; TDGA, 2-tetradecylglycidic acid; PPAR, peroxisome proliferator-activated receptor; RXR, retinoic acid receptor; CAT, chloramphenicol acetyltransferase; PPRE, peroxisome proliferator-responsive element. 'To whom correspondence should be addressed. of peroxisomes have received considerable attention after the discovery that hypolipidemic drugs induce the peroxisome proliferation and after the identification of peroxisomal diseases in human (reviewed [2] ). During the fetal-neonatal transition, there is an increase in the number of peroxisomes and in the activity of specific enzymes [3]. However, the contribution of peroxisomal /3-oxidation represents only 10-1596 of overall &oxidation in the neonatal rat liver [4, 5] .
The postnatal development of mitochondrial LCFA oxidation and ketogenesis in the liver is closely related to the appearance of the carnitine palmitoyltransferase (CPT) system and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase. The C P T system allows the transfer of LCFA inside the mitochondria and is composed of three distinct entities: CPTI localized in the outer mitochondrial membrane, carnitine-acylcarnitine translocase and CPTII localized in the inner mitochondrial membrane (reviewed in [6]; Figure 1 ). In this transfer system, CPTI represents the main site of control for the entry of LCFA into the mitochondria [6] and mitochondrial HMG-CoA synthase is the rate-limiting enzyme of the ketogenic pathway (i.e. the conversion of acetyl-CoA into ketone bodies [7] ). However, if one considers ketogenesis as the metabolic pathway converting LCFA into ketone bodies, then the C P T system is the rate-limiting step because it controls the supply of acyl-CoA for /3-oxidation and acetyl-CoA for ketogenesis [S]. Indeed, in the adult rat liver the flux control coefficient of CPTI over ketone body formation is very high (close to 1) irrespective of the nutritional state of the animal [9] . During the suckling period, CPTI exerts also a potent control over LCFA oxidation and ketogenesis but the flux control coefficient is slightly lower than in adult rat liver (0.9 versus 1.0) suggesting that other enzymes could participate in the control over pathway flux [lo].
Liver CPTI and CPTII gene expression during the fetal-neonatal transition
The activity of CPTI is very low in fetal rat liver and increases markedly during the first 24 h of
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extra-uterine life, whereas the activity of CPTII is already high in the fetal liver and does not change after birth [ 11, 121 . This developmental pattern in CPTI and CPTII maximal activities parallels that observed for immunoreactive protein concentrations [12, 13] . The postnatal increase in the amount of CPTI results from a stimulation of gene transcription [ 141, which leads to a marked accumulation of hepatic CPTI mFWA concentration during the first 24 h following birth [12, 15] (Figure 2) . The liver CPTII mRNA [ 1'2,151, immunoreactive protein [ 12, 131 and activity remain remarkably constant during development and are not influenced by nutritional and hormonal changes that occur in the immediate postnatal period (reviewed in [ 13) .
Liver mitochondrial HMG-CoA synthase gene expression during the fetalneonatal transition
Once inside the mitochondria, LCFA are rapidly oxidized into the /J-oxidation pathway, but the metabolic fate of acetyl-CoA produced (Krebs cycle versus ketone body production) is partly dependent upon the activity of mitochondrial HMG-CoA synthase, the rate-limiting enzyme in the HMG-CoA pathway (Figure 1 ). The activity of mitochondrial HMG-CoA synthase increases during the immediate postnatal period (reviewed in [ 1, 161) . In the fetal rat liver the mRNA encoding mitochondrial HMG-CoA synthase are not detectable before day 18 of pregnancy and then increase slightly until day 21 [17] . This increase This suggests that some factors contained in the milk affect CPTI gene transcription. Among these factors, carnitine and FFA are good candidates, their concentration being very low in the fasting newborn rats, as during the immediate postnatal period these substrates are only pro-
Indeed, addition of carnitine to cultured hepatocytes from fetal rats has no effect on CPTI [38] ). Finally, in Fao hepatoma cells, when longchain acyl-CoA synthetase activity was decreased by more than 90% by specific inhibitors, the stimulation of CPTI gene expression by LCFA was similar to that found in the absence of ACS inhibitors (F. Chatelain, J. Girard and J.-P. Pkgorier, unpublished work).
It is clear that all these experiments, using chimaeric gene transfection, metabolic inhibitors or in vitro assays, provide only indirect evidence for the role of FFA. However, additional work is necessary to conclude whether FFA or their CoA esters are the active modulators of gene transcription.
Contribution of nuclear receptors in the LCFA-induced gene expression
The molecular mechanisms by which FFA or fatty acyl-CoA stimulate gene transcription have not yet been identified in mammalian cells. Based on the comparison between the effects of LCFA and peroxisome proliferators it was suggested that LCFA could regulate gene transcription through the activation of nuclear receptors of the steroid-thyroid superfamily, the peroxisome proliferator-activated receptor (PPAR; reviewed in [30-321; Figure 5 ). The modulation of gene transcription is due to the binding of the heterodimer PPAR/RXR (retinoic acid receptor) to specific DNA sequences, the peroxisome proliferator-responsive element (reviewed in [30-321; Figure 5 ). In keeping with this, it has been shown that LCFA stimulate the transcription of a DNA construct consisting of HMG-CoA synthase promoter linked to a CAT reporter gene in transfected HepG2 hepatoma cells [39]. However, this stimulation by LCFA required co-transfection with a PPAR-a DNA construct. Indeed, the overexpression of nuclear receptors does not necessarily reflect physiologically relevant processes. As mentioned by the authors of this work [39], if the transcriptional effect of LCFA is due to the synthesis of a putative ligand of PPAR-a, it is difficult to understand why the LCFA-induced HMG-CoA synthase-CAT chimaeric gene does not occur from endogenous PPAR-a. Indeed, the role of PPAR in mediating transcriptional effects of LCFA is still a subject of debate. For instance, it was shown that the repression of hepatic Spot 14 gene transcription (a gene coding for a lipogenic-like enzyme) by polyunsaturated LCFA was not mediated through the activation of PPAR-a [40]. This was recently confirmed using the PPAR-a null mouse in which the induction of peroxisomal fi-oxidative genes by polyunsaturated LCFA (which are also potent peroxisome proliferators) was impaired, whereas the inhibition of Spot 14 or fatty acid synthase gene expression occurred normally [41] .
Concerning the regulation of CPTI gene expression by LCFA in fetal rat hepatocytes, indirect evidence suggests that their mode of action could be different from that of peroxisome proliferators. Firstly, LCFA induce CPTI but not CPTII gene expression whereas clofibrate (a peroxisome proliferator) enhances both CPTI and CPTII mRNA concentration in the cultured rat hepatocytes [14] (Figure 3) 
Post-transcriptional regulation of mitochondrial CPT and HMG-CoA synthase activities by metabolic effectors
Although this aspect of regulation is not the purpose of the present review, it must be underlined that following gene expression, protein translation and transport to the outer mitochondrial membrane (CPTI) or mitochondrial matrix (HMG-CoA synthase) and the activities of these enzymes are finely regulated by metabolic effectors. Such mechanisms of regulation are particularly important during the fetal-neonatal transition since they amplify the role of pancreatic hormones in the enhancement of hepatic Volume 26 fatty acid oxidation and ketogenesis. This will be briefly reviewed.
Regulation of CP T I
LCFA play a pivotal role in the post-transcriptional regulation of CPTI during the immediate postnatal period. In concert with pancreatic hormones, they inhibit the activities and expression of genes encoding key lipogenic enzymes (reviewed in [21] ). This 
Conclusions and perspectives
The regulation of specific gene expression in response to changes in nutrition has become a major aspect of modern nutrition studies. The regulation of the genes encoding P-oxidative enzymes during the perinatal period represents a very suitable model since: (i) most of these genes have never been expressed before birth (CPTI, HMG-CoA synthase); (ii) the nutritional changes occur rapidly with a large amplitude. Here we report that long-chain fatty acids in concert with pancreatic hormones (increase in plasma glucagon and decrease in plasma insulin concentrations) enhance the expression of genes coding for key mitochondrial P-oxidative enzymes in neonatal rat liver. The molecular mechanisms by which glucagon (through CAMP), insulin and LCFA regulate transcriptional and post-transcriptional events remain to be fully established. Further investigations will be necessary to characterize the intracellular metabolites (FFA or acyl-CoA esters), the transcription factors and the DNA sequences responsible for the transcriptional activation of mitochondrial P-oxidative enzyme genes by LCFA. 
